AnaptysBio, Inc. ANAB Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from AnaptysBio, Inc.’s reported figures.
Based on trailing twelve months.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s return on equity?
- AnaptysBio, Inc. (ANAB) reported return on equity of -343.8% in Q1 2025.
- How has AnaptysBio, Inc.'s return on equity changed year-over-year?
- AnaptysBio, Inc.'s return on equity decreased by 151.5% year-over-year, from -136.7% to -343.8%.
- What is the long-term trend for AnaptysBio, Inc.'s return on equity?
- Over 3 years (2021 to 2024), AnaptysBio, Inc.'s return on equity has grown at a 128.3% compound annual growth rate (CAGR), from -15.3% to -182.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.